Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Endocrinology
Volume 2013, Article ID 308086, 3 pages
http://dx.doi.org/10.1155/2013/308086
Case Report

Nonislet Cell Tumor Hypoglycemia

Department of Endocrinology, Diabetes & Metabolism, Nassau University Medical Center, East Meadow, NY 11554, USA

Received 14 June 2013; Accepted 2 September 2013

Academic Editors: G. Aimaretti, J. P. Frindik, K. Iida, O. Isozaki, L. Mastrandrea, and T. Nagase

Copyright © 2013 Johnson Thomas and Salini C. Kumar. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. H. Nadler and J. A. Wolfer, “Hepatogenic hypoglycemia associated with primary liver cell carcinoma,” Archives of Internal Medicine, vol. 44, pp. 700–705, 1929. View at Google Scholar
  2. W. H. Daughaday, M. A. Emanuelle, M. H. Brooks, A. L. Barbato, M. Kapadia, and P. Rotwein, “Synthesis and secretion of insulin-like growth factor II by a leiomyosarcoma with associated hypoglycemia,” The New England Journal of Medicine, vol. 319, no. 22, pp. 1434–1440, 1988. View at Google Scholar · View at Scopus
  3. V. Marks and J. D. Teale, “Tumours producing hypoglycaemia,” Diabetes/Metabolism Reviews, vol. 7, no. 2, pp. 79–91, 1991. View at Google Scholar · View at Scopus
  4. J. Zapf, E. Futo, M. Peter, and E. R. Froesch, “Can “big” insulin-like growth factor II in serum of tumor patients account for the development of extrapancreatic tumor hypoglycemia?” The Journal of Clinical Investigation, vol. 90, no. 6, pp. 2574–2584, 1992. View at Google Scholar · View at Scopus
  5. N. Hizuka, I. Fukuda, K. Takano, Y. Okubo, K. Asakawa-Yasumoto, and H. Demura, “Serum insulin-like growth factor II in 44 patients with non-islet cell tumor hypoglycemia,” Endocrine Journal, vol. 45, supplement, pp. S61–S65, 1998. View at Google Scholar · View at Scopus
  6. F. Frasca, G. Pandini, P. Scalia et al., “Insulin receptor isoform A, a newly recognized, high-affinity insulin- like growth factor II receptor in fetal and cancer cells,” Molecular and Cellular Biology, vol. 19, no. 5, pp. 3278–3288, 1999. View at Google Scholar · View at Scopus
  7. J. W. B. de Groot, B. Rikhof, J. Van Doorn et al., “Non-islet cell tumour-induced hypoglycaemia: a review of the literature including two new cases,” Endocrine-Related Cancer, vol. 14, no. 4, pp. 979–993, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Hoekman, J. van Doorn, T. Gloudemans, J. A. Maassen, A. G. P. Schuller, and H. M. Pinedo, “Hypoglycaemia associated with the production of insulin-like growth factor II and insulin-like growth factor binding protein 6 by a haemangiopericytoma,” Clinical Endocrinology, vol. 51, no. 2, pp. 247–253, 1999. View at Publisher · View at Google Scholar · View at Scopus
  9. J. van Doorn, C. M. Hoogerbrugge, J. G. Koster et al., “Antibodies directed against the E region of pro-insulin-like growth factor-II used to evaluate non-islet cell tumor-induced hypoglycemia,” Clinical Chemistry, vol. 48, no. 10, pp. 1739–1750, 2002. View at Google Scholar · View at Scopus
  10. B. Hirshberg, C. Cochran, M. C. Skarulis et al., “Malignant insulinoma: spectrum of unusual clinical features,” Cancer, vol. 104, no. 2, pp. 264–272, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. J. D. Teale and V. Marks, “Glucocorticoid therapy suppresses abnormal secretion of big IGF-II by non-islet cell tumours inducing hypoglycaemia (NICTH),” Clinical Endocrinology, vol. 49, no. 4, pp. 491–498, 1998. View at Publisher · View at Google Scholar · View at Scopus
  12. J. D. Teale and G. Wark, “The effectiveness of different treatment options for non-islet cell tumour hypoglycaemia,” Clinical Endocrinology, vol. 60, no. 4, pp. 457–460, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. N. Bourcigaux, G. Arnault-Ouary, R. Christol, L. Périn, B. Charbonnel, and Y. Le Bouc, “Treatment of hypoglycemia using combined glucocorticoid and recombinant human growth hormone in a patient with a metastatic non-islet cell tumor hypoglycemia,” Clinical Therapeutics, vol. 27, no. 2, pp. 246–251, 2005. View at Publisher · View at Google Scholar · View at Scopus